Related references
Note: Only part of the references are listed.Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis
S. Stefani et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Liposome-based drug co-delivery systems in cancer cells
Sepideh Zununi Vahed et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments
Thomas Tangden et al.
INFECTIOUS DISEASES (2017)
Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors
Trang D. Trinh et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Colistin-entrapped liposomes driven by the electrostatic interaction: Mechanism of drug loading and in vivo characterization
Yang Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug
David Cipolla et al.
PHARMACEUTICAL RESEARCH (2016)
Inhaled formulations and pulmonary drug delivery systems for respiratory infections
Qi (Tony) Zhou et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
A review on colistin nephrotoxicity
Atefeh Ordooei Javan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
Neang S. Ly et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens
Leo Lin et al.
EBIOMEDICINE (2015)
Activities of Antibiotic Combinations against Resistant Strains of Pseudomonas aeruginosa in a Model of Infected THP-1 Monocytes
Julien M. Buyck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans
David Cipolla et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria
Zakuan Z. Deris et al.
BIOCONJUGATE CHEMISTRY (2014)
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
Pritesh P. Jain et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles
A. Alinaghi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Modifying the Release Properties of Liposomes Toward Personalized Medicine
David Cipolla et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Development and Characterization of an In Vitro Release Assay for Liposomal Ciprofloxacin for Inhalation
David Cipolla et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics
Tony Velkov et al.
FUTURE MICROBIOLOGY (2013)
Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies
Stephanie J. Wallace et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
Celine Vidaillac et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles
Michal Bachar et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Interaction of colistin and colistin methanesulfonate with liposomes: Colloidal aspects and implications for formulation
Stephanie J. Wallace et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity
Jerzy Gubernator
EXPERT OPINION ON DRUG DELIVERY (2011)
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
Rajesh V. Dudhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
N. Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Anima Poudyal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro Pharmacokinetic/Pharmacodynamic model
Chun-Hong Tan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa
EJ Giamarellos-Bourboulis et al.
JOURNAL OF CHEMOTHERAPY (2003)
In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate
TR Desai et al.
PHARMACEUTICAL RESEARCH (2003)
Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection
A Omri et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Share Paper
